{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:39:37Z","timestamp":1780760377325,"version":"3.54.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Action myoclonus-renal failure syndrome (AMRF) is a rare, recessively inherited form of progressive myoclonus epilepsy (PME) caused by mutations in the SCARB2 gene and associated with end-stage renal failure. In addition to severe progressive myoclonus, the neurological manifestations of this syndrome are characterized by progressive ataxia and dysarthria with preserved intellectual capacity. Since its original description, an increasing number of \u201cAMRF-like\u201d cases without renal failure have been reported. We describe the case of a 29-year-old woman with progressive disabling myoclonus associated with dysarthria and ataxia who was found to have a novel homozygous frameshift mutation in the SCARB2 gene. In addition, this report emphasizes the presence of two EEG patterns, fixation-off phenomenon, and bursts of parasagittal spikes exclusively seen during REM sleep that appear to be characteristic of this condition.<\/jats:p>","DOI":"10.3389\/fgene.2020.581253","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T08:06:31Z","timestamp":1606982791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Distinctive EEG Patterns in SCARB-2 Related Progressive Myoclonus Epilepsy"],"prefix":"10.3389","volume":"11","author":[{"given":"Mostafa","family":"Hotait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Dirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"El Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"B1","unstructured":"Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology87103\n            AndermannE.\n            AndermannF.\n            CarpenterS.\n            WolfeL. S.\n            NelsonR.\n            PatryG.\n          3946122Adv. Neurol.431986"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1684\/epd.2016.0835","article-title":"Neurophysiology of myoclonus and progressive myoclonus epilepsies","volume":"18","author":"Avanzini","year":"2016","journal-title":"Epileptic Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/14737175.2018.1503949","article-title":"New discoveries in progressive myoclonus epilepsies: a clinical outlook","volume":"18","author":"Bhat","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.clinph.2012.07.017","article-title":"Fixation-off sensitivity","volume":"124","author":"Brigo","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/epi.13662","article-title":"Perampanel in 12 patients with Unverricht-Lundborg disease","volume":"58","author":"Crespel","year":"2017","journal-title":"Epilepsia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.21765","article-title":"SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure","volume":"66","author":"Dibbens","year":"2009","journal-title":"Ann. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebcr.2014.09.003","article-title":"Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel","volume":"2","author":"Dirani","year":"2014","journal-title":"Epilepsy Behav Case Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.eplepsyres.2006.10.006","article-title":"Long-term evolution of EEG in Unverricht-Lundborg disease","volume":"73","author":"Ferlazzo","year":"2007","journal-title":"Epilepsy Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-2008-1052480","article-title":"The syndrome of myoclonic epilepsy with ragged-red fibers. Report of a case and review of the literature","volume":"18","author":"Garcia Silva","year":"1987","journal-title":"Neuropediatrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yebeh.2016.06.041","article-title":"Efficacy and tolerability of perampanel in ten patients with Lafora disease","volume":"62","author":"Goldsmith","year":"2016","journal-title":"Epilepsy Behav."},{"key":"B13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2377-11-134","article-title":"Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features","volume":"11","author":"Hopfner","year":"2011","journal-title":"BMC Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1684\/epd.2009.0235","article-title":"Fixation-off sensitivity in epilepsies other than the idiopathic epilepsies of childhood with occipital paroxysms: a 12-year clinical-video EEG study","volume":"11","author":"Koutroumanidis","year":"2009","journal-title":"Epileptic Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1212\/01.wnl.0000216147.12172.39","article-title":"Fixation-sensitive myoclonus in Lafora disease","volume":"66","author":"Kumada","year":"2006","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1111\/j.1528-1167.2011.03307.x","article-title":"Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations","volume":"52","author":"Rubboli","year":"2011","journal-title":"Epilepsia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14737175.2020.1713101","article-title":"Advances in genetic testing and optimization of clinical management in children and adults with epilepsy","volume":"20","author":"Scala","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0370-4475(74)80052-3","article-title":"Electroencephalographic study of myoclonic cerebellar dyssynergia with epilepsy (Ramsay-Hunt syndrome)","volume":"4","author":"Tassinari","year":"1974","journal-title":"Rev. Electroencephalogr. Neurophysiol. Clin."},{"key":"B19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.seizure.2018.03.015","article-title":"Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review","volume":"57","author":"Tian","year":"2018","journal-title":"Seizure"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.581253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T08:06:44Z","timestamp":1606982804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.581253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":19,"alternative-id":["10.3389\/fgene.2020.581253"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2020.581253","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"article-number":"581253"}}